CYP2C9 and acute myeloid leukemia: The IC50 values for R- and S-AML were 13.16 μM and 44.92 μM, respectively; against CYP2C9*1/*1; 12.98 μM and 53.19 μM, respectively; against CYP2C9*1/*2; 8.88 μM and 19.15 μM, respectively; against CYP2C19*1/*1; and 7.12 μM and 10.30 μM, respectively; against CYP2C19*1/*2.